Overview
LL-37 is included in this independent research library to separate what has been demonstrated from what remains theoretical. The evidence, regulatory status and terminology vary substantially by compound, so claims should be read in the context of the cited literature.
LL-37 suggested dosing guide
A concise reference to the dosing ranges most often used in approved labeling, clinical research, or published research discussions. Evidence strength is shown so established dosing is not confused with experimental protocol.
Titration and protocol notes
LL-37 can have complex pro-inflammatory and cytotoxic effects; avoid inventing a protocol from preclinical work.
Annotated dosage protocol
Each row explains what the dosage represents. Read it with the evidence badge above: labeled doses, clinical-trial doses, and commonly discussed research amounts do not carry equal clinical weight.
| Phase | Dose | Schedule | What this dosage means |
|---|---|---|---|
| Lower reference | No established human dose | Not established | The lower end reported in research discussions; it is not a validated human starting prescription. |
| Commonly cited range | No validated human dosing range | Not established | A range repeated in reference protocols. Repetition does not establish safety, efficacy, or an approved regimen. |
| Duration / reassessment | Not established | Reassess before continuing | LL-37 can have complex pro-inflammatory and cytotoxic effects; avoid inventing a protocol from preclinical work. Dose changes should never be inferred from vial size or convenient syringe units. |
LL-37 reconstitution example
This worked example uses a 10 mg vial, 2 mL of diluent, and a 100 mcg reference amount.
Syringe units assume a U-100 syringe. Always verify the vial label, syringe type, formulation, and arithmetic independently.
Safety, handling, and storage
- Suggested ranges are educational summaries, not individualized prescriptions.
- FDA-labeled regimens apply only to the approved product, indication, and delivery system.
- For experimental compounds, human safety, purity, and effective dosing may be unknown.
- Follow product-specific sterility, storage, and beyond-use instructions; do not use damaged or contaminated material.
LL-37 calculator
Enter your laboratory values to calculate concentration, draw volume, syringe units, and portions per vial.
Deterministic arithmetic for laboratory documentation only. This tool does not select a dose, provide a protocol, or replace qualified medical or laboratory guidance.
Mechanism and research rationale
An endogenous host-defense peptide that can disrupt microbial membranes and influence innate immune signaling, inflammation and wound responses.
Innate immunity
Antimicrobial research
Wound biology
Key facts
- Evidence tier: Preclinical and observational.
- Research status and regulatory status are not interchangeable.
- This page is an educational reference and does not provide personal medical instructions.